Senior Director Alliances
Takeda Pharmaceuticals, California, United States
Cathy Tralau-Stewart PhD – Senior Director Alliances Takeda Pharmaceuticals
Cathy has many years’ experience of leading drug discovery programs from target validation through to patients. She is a pharmacologist and has been involved in, and has led teams which created over 13 marketed products and many candidate compounds. She gained her PhD at University College London and lead groups and projects focused on pre-clinical through to clinical drug discovery for GlaxoSmithKline. Cathy led the development of academic-industry drug discovery at Imperial College London and subsequently at University of California San Francisco (UCSF). At UCSF Cathy led the Innovative Catalyst translational program, supporting the succesful development of novel therapeutic, diagnostic, digital health and device products to exits such as licenses, start-up company formation and partnerships. In April 2018, Cathy joined Takeda to lead academic alliances and the development of academic Start-up companies in collaboration with Takeda .
Cathy is also a Visiting Scholar at Stanford ChEM-H contributing to Stanford SPARK and Adjunct Associate Professor Bioengineering & Therapeutics at UCSF.
Enabling the translation of novel academic science to patients is Cathy’s mission.
Disclosure information not submitted.
Monday, February 7, 2022
10:00 AM – 11:30 AM
Monday, February 7, 2022
1:00 PM – 2:30 PM
Monday, February 7, 2022
4:00 PM – 5:30 PM
Tuesday, February 8, 2022
10:00 AM – 11:30 AM
Tuesday, February 8, 2022
1:00 PM – 2:30 PM
Tuesday, February 8, 2022
4:00 PM – 5:30 PM
Wednesday, February 9, 2022
10:00 AM – 11:30 AM